Martine Rothblatt

2013

In 2013, Martine Rothblatt earned a total compensation of $38.2M as Chairman and Co-Chief Executive Officer at United Therapeutics, a 380% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,102,907
Option Awards$36,097,326
Salary$992,678
Other$25,344
Total$38,218,255

Rothblatt received $36.1M in option awards, accounting for 94.45% of the total pay in 2013.

Rothblatt also received $1.1M in non-equity incentive plan, $992.7K in salary and $25.3K in other compensation.

Overall ranking

Ranking

20

out of 12,114
Percentile100th

Martine Rothblatt's 2013 compensation ranked 20th out of 12,114 executive pay records tracked by us this year.

Rothblatt earned more than 99.8% of all executives tracked by us in 2013.

Ranking in industry group

Industry groupDrugs
Ranking

1

out of 1,115
Percentile100th

In the industry group of Drugs, Rothblatt's pay ranked 1st out of 1,115 executive pay records tracked by us in 2013.

Rothblatt earned more than 99.9% of executives in this group.

Source: SEC filing on April 28, 2016.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2013.

2013

Roger Jeffs

United Therapeutics

Chief Executive Officer

2013

John Ferrari

United Therapeutics

Chief Financial Officer

2013

Paul Mahon

United Therapeutics

General Counsel

News

In-depth

You may also like